Lars Sörén
Linköping University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lars Sörén.
Scandinavian Journal of Infectious Diseases | 1989
Jan Sörensen; Pia Forsberg; Erik Håkanson; Rolf Maller; Christer Sederholm; Lars Sörén; Christer Carlsson
36 patients with severe community-acquired pneumonia, treated in an intensive care unit (ICU), were examined in a prospective study using a comprehensive diagnostic program to establish an early etiological diagnosis. The resulting prompt and adequate antimicrobial therapy may have decreased the number of fatal cases. Special emphasis was placed on the use of a method incorporating fiberoptic bronchoscopy, together with protected brush sampling and bronchial lavage. An etiological diagnosis was established in 81% (29/36) of the cases. This etiological diagnosis was established within 48-72 h in 53% (19/36) of the patients, S. pneumoniae being the most frequent agent found (12 patients). This information, however, was poorly utilized since in only 11/19 of these patients was the antimicrobial therapy changed from a broad-spectrum antibiotic to a more specific narrow spectrum agent. The overall mortality rate was 22% (8/36). 7/8 patients who died had compromising factors. Most deaths in community-acquired pneumonia are still associated with pneumococcal infection. We conclude that fiberoptic bronchoscopy with brush samples via a plugged double lumen catheter provides the least misleading information concerning the etiological agent in pneumonia; sampling should be done as soon as possible after admission to the hospital, ideally before the need for ICU treatment; factors other than prompt antimicrobial therapy may influence the outcome of severe community-acquired pneumonia.
Acta Anaesthesiologica Scandinavica | 1999
C.‐M. Erlandsson; Håkan Hanberger; I. Eliasson; Mikael Hoffmann; Barbro Isaksson; S. Lindgren; Lennart E. Nilsson; Lars Sörén; Sten Walther
Background: A study was designed to assess a computer‐based program for continuous registration of antibiotic resistance, statistics concerning severity of illness, and consumption of antibacterial drugs.
Acta Pathologica Microbiologica Scandinavica Section C Immunology | 2009
Rolf Maller; Lars Sörén
Investigation has been made of the specific in vitro stimulation of human lymphocytes by live or inactivated rubella virus of the strain RA 27/3. The thymidine incorporation of lymphocytes from blood donors with different serological immunity against rubella was measured following incubation with the viral antigens. UV-inactivated rubella virus caused a moderate degree of stimulation of lymphocytes from seropositive individuals. On the other hand, live rubella virus stimulated lymphocytes from donors with low titres of anti-rubella HI-antibodies but not lymphocytes from donors with high antibody titres. Possible explanations for this discrepancy are discussed.
Journal of Antimicrobial Chemotherapy | 1988
Barbro Isaksson; Lennart Nilsson; Rolf Maller; Lars Sörén
Journal of Antimicrobial Chemotherapy | 1988
Rolf Maller; Barbro Isaksson; Lennart E. Nilsson; Lars Sörén
Journal of Antimicrobial Chemotherapy | 1999
Håkan Hanberger; Lennart E. Nilsson; B Claesson; A Kärnell; P Larsson; M Rylander; Erik Svensson; Mikael Sörberg; Lars Sörén
Journal of Antimicrobial Chemotherapy | 1987
Lennart Nilsson; Lars Sörén; Gunilla Rådberg
Journal of Antimicrobial Chemotherapy | 1986
Lennart Nilsson; Lars Sörén
Journal of Antimicrobial Chemotherapy | 1992
G. Rädberg; Lennart E. Nilsson; E. Kihiström; Rolf Maller; Lars Sörén
Acta Pathologica Microbiologica Scandinavica Section C Immunology | 2009
Rolf Maller; Lars Sörén